GoodRx Holdings, Inc. (NASDAQ: GDRX)

GoodRx Holdings, Inc. operates a consumer focused digital healthcare platform in the United States that provides price transparency and affordability solutions for prescription medications and related healthcare services. The company’s mission is to help Americans save time and money when filling their medications by removing friction and inefficiencies in the system. Users can search for lower drug prices, access telehealth visits and subscribe to enhanced savings programs through the platform.

Revenue is generated primarily through fees paid by pharmacy benefit managers and pharmacies each time a consumer uses a GoodRx code to obtain a discounted prescription, through subscription fees for offerings such as Gold, RxSmartSaver+, and condition specific programs, and through payments from pharmaceutical manufacturers for advertising and integrating their affordability solutions on the platform. Additionally, the company earns revenue from telehealth visits offered via its subscription services, where patients pay for virtual consultations outside of insurance. These streams together constitute the core of GoodRx’s business model.

The company operates through the following segments: Prescription Marketplace, Subscription Offerings, and Pharma Direct Offering.

• Prescription Marketplace: This segment aggregates pricing data from pharmacy benefit managers, pharmacies, manufacturers, and other sources to deliver geographically relevant prescription prices and free GoodRx codes, earning revenue from fees paid by PBMs and pharmacies upon each code use while also providing consumers with tools to compare prices across nearby pharmacies and track savings over time.

• Subscription Offerings: This segment includes Gold, RxSmartSaver+, and condition specific programs that charge monthly or annual fees for enhanced discounts, mail delivery, telehealth access, and bundled care services, providing recurring revenue from subscribers and offering benefits such as lower drug prices at select pharmacies, free home delivery on eligible medications, and virtual consultations with healthcare professionals.

• Pharma Direct Offering: This segment partners with pharmaceutical manufacturers to advertise and integrate copay cards, patient assistance programs, and consumer direct pricing, earning fees for driving uptake of brand medication affordability solutions and helping manufacturers increase patient awareness, adherence, and overall demand for their products.

GoodRx holds a leading position in the U. S. prescription price transparency market, competing with fragmented coupon sites, large e commerce platforms, and health focused apps. Its competitive advantages stem from a proprietary pricing database that processes hundreds of billions of data points daily, extensive relationships with dozens of PBMs and pharmacy chains, and a strong consumer brand that drives high engagement and network effects. The company also benefits from high repeat usage of its discounts, which creates a durable moat as consumers return to the same pharmacy after realizing savings, reinforcing the value proposition for both users and partners. While new entrants may appear, the scale of data and network relationships required to replicate the platform presents a significant barrier to entry. The firm continues to invest in new product categories such as employer direct solutions and clinical trial enrollment tools to expand its addressable market.

The platform serves individual consumers seeking lower prescription costs, healthcare providers who use the tool to inform patients at the point of care, pharmacies that benefit from increased foot traffic and adherence programs, and pharmaceutical manufacturers that leverage the service to promote affordability initiatives. Consumers range from the uninsured looking for cash prices to insured individuals seeking lower out of pocket costs than their plan copays. Healthcare providers include physicians and pharmacists who integrate GoodRx pricing into electronic health records or recommend the service to patients during visits. While specific partner names are not disclosed in the excerpt, the company notes relationships with major pharmacy chains and numerous PBMs across the United States.